QUINALAN Drug Patent Profile
✉ Email this page to a colleague
When do Quinalan patents expire, and when can generic versions of Quinalan launch?
Quinalan is a drug marketed by Chartwell Molecular and is included in one NDA.
The generic ingredient in QUINALAN is quinidine gluconate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the quinidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinalan
A generic version of QUINALAN was approved as quinidine gluconate by SUN PHARM INDUSTRIES on February 11th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUINALAN?
- What are the global sales for QUINALAN?
- What is Average Wholesale Price for QUINALAN?
Summary for QUINALAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Patent Applications: | 1,422 |
| DailyMed Link: | QUINALAN at DailyMed |
US Patents and Regulatory Information for QUINALAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecular | QUINALAN | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 088081-001 | Feb 10, 1986 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
